Henry R Shinefield

Summary

Publications

  1. ncbi Overview of the development and current use of CRM(197) conjugate vaccines for pediatric use
    Henry R Shinefield
    Vaccine 28:4335-9. 2010
  2. ncbi Staphylococcal infections: a historical perspective
    Henry R Shinefield
    University of California in San Francisco, San Francisco, CA, USA
    Infect Dis Clin North Am 23:1-15. 2009
  3. ncbi Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine
    Henry R Shinefield
    Department of Pediatrics, University of California at San Francisco School of Medicine, San Francisco, California, USA
    J Infect Dis 197:S152-5. 2008
  4. ncbi Use of a conjugate polysaccharide vaccine in the prevention of invasive staphylococcal disease: is an additional vaccine needed or possible?
    Henry R Shinefield
    Pediatrics and Dermatology, University of California, San Francisco, 400 Parnassus Avenue, San Francisco, CA 94143, USA
    Vaccine 24:S2-65-9. 2006
  5. ncbi Prevention of Staphylococcus aureus infections: advances in vaccine development
    Henry R Shinefield
    University of California School of Medicine, San Francisco, CA 94109, USA
    Expert Rev Vaccines 4:669-76. 2005
  6. ncbi Prospects for active and passive immunization against Staphylococcus aureus
    Henry R Shinefield
    University of California, San Francisco, CA, USA
    Pediatr Infect Dis J 25:167-8. 2006
  7. ncbi Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children
    Henry R Shinefield
    Kaiser Permanente Vaccine Study Group, Oakland, CA 94612, USA
    Pediatr Infect Dis J 21:555-61. 2002
  8. ncbi Polio extraimmunization in children younger than 2 years after changes in immunization recommendations
    Loren K Mell
    Center for Health Studies, Group Health Cooperative, Seattle, Washington, USA
    Pediatrics 111:296-301. 2003
  9. ncbi Childhood vaccinations and risk of asthma
    Frank Destefano
    Centers for Disease Control and Prevention, Atlanta, GA, USA
    Pediatr Infect Dis J 21:498-504. 2002
  10. ncbi Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants
    Eric K France
    Department of Preventive Medicine and Clinical Research Unit, Kaiser Permanente Colorado, Denver, CO 80231, USA
    Arch Pediatr Adolesc Med 160:1277-83. 2006

Collaborators

Detail Information

Publications17

  1. ncbi Overview of the development and current use of CRM(197) conjugate vaccines for pediatric use
    Henry R Shinefield
    Vaccine 28:4335-9. 2010
    ..This paper focuses on the use of CRM(197) as a carrier protein, contrasting it to other carrier proteins used in single-antigen pediatric vaccines as well as identifying areas for future study...
  2. ncbi Staphylococcal infections: a historical perspective
    Henry R Shinefield
    University of California in San Francisco, San Francisco, CA, USA
    Infect Dis Clin North Am 23:1-15. 2009
    ..With such information, it may be possible to develop a vaccine that will prevent endemic and epidemic staphylococcal disease...
  3. ncbi Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine
    Henry R Shinefield
    Department of Pediatrics, University of California at San Francisco School of Medicine, San Francisco, California, USA
    J Infect Dis 197:S152-5. 2008
    ....
  4. ncbi Use of a conjugate polysaccharide vaccine in the prevention of invasive staphylococcal disease: is an additional vaccine needed or possible?
    Henry R Shinefield
    Pediatrics and Dermatology, University of California, San Francisco, 400 Parnassus Avenue, San Francisco, CA 94143, USA
    Vaccine 24:S2-65-9. 2006
    ..In particular, the success of a Phase 3 clinical study of a vaccine directed at capsular polysaccharides types 5 and 8 is discussed...
  5. ncbi Prevention of Staphylococcus aureus infections: advances in vaccine development
    Henry R Shinefield
    University of California School of Medicine, San Francisco, CA 94109, USA
    Expert Rev Vaccines 4:669-76. 2005
    ..In particular, the results of a Phase III clinical study of a vaccine directed at capsular polysaccharides types 5 and 8 are discussed...
  6. ncbi Prospects for active and passive immunization against Staphylococcus aureus
    Henry R Shinefield
    University of California, San Francisco, CA, USA
    Pediatr Infect Dis J 25:167-8. 2006
  7. ncbi Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children
    Henry R Shinefield
    Kaiser Permanente Vaccine Study Group, Oakland, CA 94612, USA
    Pediatr Infect Dis J 21:555-61. 2002
    ....
  8. ncbi Polio extraimmunization in children younger than 2 years after changes in immunization recommendations
    Loren K Mell
    Center for Health Studies, Group Health Cooperative, Seattle, Washington, USA
    Pediatrics 111:296-301. 2003
    ..CONCLUSIONS: Poliovirus extraimmunization rates have fallen dramatically in association with the change-over to the all inactivated polio virus schedule...
  9. ncbi Childhood vaccinations and risk of asthma
    Frank Destefano
    Centers for Disease Control and Prevention, Atlanta, GA, USA
    Pediatr Infect Dis J 21:498-504. 2002
    ..The weak associations for Hib and hepatitis B vaccines seem to be at least partially accounted for by health care utilization or information bias...
  10. ncbi Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants
    Eric K France
    Department of Preventive Medicine and Clinical Research Unit, Kaiser Permanente Colorado, Denver, CO 80231, USA
    Arch Pediatr Adolesc Med 160:1277-83. 2006
    ..To determine whether influenza vaccination of pregnant women prevents visits for respiratory illness in their infants born during the influenza season...
  11. ncbi Lack of association between receipt of conjugate haemophilus influenzae type B vaccine (HbOC) in infancy and risk of type 1 (juvenile onset) diabetes: long term follow-up of the HbOC efficacy trial cohort
    Steven B Black
    Kaiser Permanente Vaccine Study Center, Oakland, CA 94612, USA
    Pediatr Infect Dis J 21:568-9. 2002
    ..These children are now 10 to 12 years of age. We found no evidence that vaccination with Hib conjugate vaccine in infancy is associated with risk of diabetes later in life...
  12. ncbi Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine
    Arnd M Herz
    Department of Pediatrics and Pediatric Infectious Disease, Kaiser Permanente, Hayward, CA 94545, USA
    Pediatr Infect Dis J 25:293-300. 2006
    ..The introduction of routine vaccination with heptavalent conjugated pneumococcal vaccine has changed the overall incidence of bacteremia in children 3 months-3 years old...
  13. ncbi Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine
    Timo Vesikari
    University of Tampere Medical School, Tampere, Finland
    N Engl J Med 354:23-33. 2006
    ..The risk of intussusception was similar in vaccine and placebo recipients. (ClinicalTrials.gov number, NCT00090233.)..
  14. ncbi Hepatitis B vaccination among adolescents in 3 large health maintenance organizations
    Idalia M Gonzalez
    Epidemiology Program Office, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Pediatrics 110:929-34. 2002
    ..Little is known about the implementation of these recommendations in a managed care setting. The objective of this study was to determine the impact of ACIP recommendations on HB vaccination among adolescents in 3 managed care settings...
  15. ncbi Compliance with national immunization guidelines for children younger than 2 years, 1996-1999
    Loren K Mell
    Center for Health Studies, Group Health Cooperative, Seattle, Washington, USA
    Pediatrics 115:461-7. 2005
    ..6% of children were compliant with prevailing childhood immunization recommendations from 1996 to 1999. Efforts to improve compliance with guidelines are recommended, to optimize childhood infectious disease prevention...
  16. ncbi Vaccinations and risk of central nervous system demyelinating diseases in adults
    Frank Destefano
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Arch Neurol 60:504-9. 2003
    ..Several case reports of the onset or exacerbation of multiple sclerosis or other demyelinating conditions shortly after vaccination have suggested that vaccines may increase the risk of demyelinating diseases...
  17. ncbi Observed costs and health care use of children in a randomized controlled trial of pneumococcal conjugate vaccine
    G Thomas Ray
    Division of Research, Kaiser Permanente Medical Care Program, Oakland, CA 94611, USA
    Pediatr Infect Dis J 21:361-5. 2002
    ..Pneumococcal conjugate vaccine for infants has recently been found to be effective for prevention of meningitis, bacteremia, pneumonia and otitis media, but it is more costly than previously introduced vaccines...